Archived copies of the webcasts will be available for up to one year by visiting the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.

Avirmax's Chief Executive and Scientific Officer, Dr. Shengjiang Shawn Liu, Ph.D., will chair the upcoming session of " Acceleration of AAV Gene Therapy for Ocular Diseases: Improving Delivery and ...

It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal ...

Blog - The World Health Organization (WHO) has identified climate change as one of humanity's most significant health threat, with significant impacts across Africa. Rising temperatures and erratic ...

Hinton moved to the University of Toronto in 1987 and began attracting young researchers who wanted to study neural networks.

Most discussion of gene and cell therapy costs focuses on increasing manufacturing efficiency but reducing costs can only go ...

Q3 2024 Earnings Call Transcript November 7, 2024 The Trade Desk, Inc. beats earnings expectations. Reported EPS is $0.41, ...

The Capital is readying for the 2024 edition of Shopping Centres Next (SCN) on the 13th and 14th of November, 2024 at Pullman ...

conference. The presentation reviewed the robust preclinical findings informing vector and dose selection and demonstrated the positive effects of elevating progranulin levels in vivo. Preclinical non ...

RJVA-002 is a locally administered AAV9 viral vector that expresses human GIP and GLP-1 hormones ... key company milestones into the fourth quarter of 2025. Webcast and Conference Call Information ...

VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (TSX: COPR) (“Coppernico” or the “Company”), is pleased to ...

America needs partners in Eurasia who can help Washington at a time when Moscow and Beijing are trying to undermine the ...